Galectin-1-Dependent Mitochondria Apoptosis Plays an Essential Role in the Potential Protein Targets of DBDCT-Induced Hepatotoxicity As Revealed by Quantitative Proteomic Analyses

Overview

Journal Bioinorg Chem Appl

Publisher Wiley

Date 2022 Feb 14

PMID 35154294

Authors

Jiayu Song

Yuan Ren

Lihua Liu

Yixin Wang

Chuandao Shi

Xiaoqing Ji

Yunlan Li

Qingshan Li

Affiliations

Soon will be listed here.

Abstract

Di-n-butyl-di-(4-chlorobenzohydroxamato) tin(IV) (DBDCT), a new patent agent, exhibited strong antitumor activity. In some cases, its activity was close to or even higher than cisplatin, a first-line clinical metallic agent. Similar to platinum compounds, it also showed toxicity. However, the effective targets and mechanisms for specific toxicity and biological activity are still unclear. In this study, proteomic analysis revealed that 146 proteins (98 upregulated and 48 downregulated) were differentially identified by label-free LC-MS/MS after DBDCT treatment. Meanwhile, network analysis of these differential proteins suggested that protein Galectin-1 (Gal-1) could regulate the apoptosis process (15 related proteins), which played an essential role in the potential targets of DBDCT-induced hepatotoxicity. Furthermore, it was demonstrated that DBDCT might promote ROS production, activate NF-B p65, inhibit Ras and p-ERK1/2 expressions, increase the level of Gal-1, subsequently upregulate the expressions of Bax, p53, Fas, and FasL, and downregulate the expression of Bcl-2. As a result of these modulations, caspase cascades were finally activated, which executed apoptosis in HL7702 liver cells. Correspondingly, NAC (inhibitor of ROS), PDTC (inhibitor of NF-B), EGF (ERK1/2 activator), and OTX008 (inhibitor of Gal-1) were found to reverse and abolish the DBDCT-associated cytotoxicity partially. In conclusion, Gal-1 might be the potential target for toxicity and biological activity. Moreover, the present study will lay the groundwork for future research about di-n-butyl-di-(4-chlorobenzohydroxamato) tin structure optimization and developing it into a new potential anticancer agent.

References

Zhu H, Tan L, Li Y, Li J, Qiu M, Li L . Increased Apoptosis in the Paraventricular Nucleus Mediated by AT1R/Ras/ERK1/2 Signaling Results in Sympathetic Hyperactivity and Renovascular Hypertension in Rats after Kidney Injury. Front Physiol. 2017; 8:41. PMC: 5288364. DOI: 10.3389/fphys.2017.00041. View

Ren F, Fang Q, Xi H, Feng T, Wang L, Hu J . Platelet-derived growth factor-BB and epidermal growth factor promote dairy goat spermatogonial stem cells proliferation via Ras/ERK1/2 signaling pathway. Theriogenology. 2020; 155:205-212. DOI: 10.1016/j.theriogenology.2020.06.012. View

Goud N, Soukya P, Ghouse M, Komal D, Alvala R, Alvala M . Human Galectin-1 and Its Inhibitors: Privileged Target for Cancer and HIV. Mini Rev Med Chem. 2019; 19(16):1369-1378. DOI: 10.2174/1389557519666190304120821. View

Toscano M, Campagna L, Molinero L, Cerliani J, Croci D, Ilarregui J . Nuclear factor (NF)-κB controls expression of the immunoregulatory glycan-binding protein galectin-1. Mol Immunol. 2011; 48(15-16):1940-9. DOI: 10.1016/j.molimm.2011.05.021. View

Huang X, Liu W, Zhou Y, Sun M, Yang H, Zhang C . Galectin-1 ameliorates lipopolysaccharide-induced acute lung injury via AMPK-Nrf2 pathway in mice. Free Radic Biol Med. 2019; 146:222-233. DOI: 10.1016/j.freeradbiomed.2019.11.011. View

Chen L, Yao Y, Sun L, Tang J . Galectin-1 promotes tumor progression via NF-κB signaling pathway in epithelial ovarian cancer. J Cancer. 2017; 8(18):3733-3741. PMC: 5688927. DOI: 10.7150/jca.20814. View

Echigo Y, Sugiki H, Koizumi Y, Hikitsuchi S, Inoue H . Activation of RAW264.7 macrophages by oxidized galectin-1. Immunol Lett. 2010; 131(1):19-23. DOI: 10.1016/j.imlet.2010.03.010. View

Brandt B, Buchse T, Abou-Eladab E, Tiedge M, Krause E, Jeschke U . Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes. Histochem Cell Biol. 2008; 129(5):599-609. DOI: 10.1007/s00418-008-0395-x. View

Tang L, Luo J, Li Y, Ge R, Li Q . Hepatotoxicity and proteomic mechanism of Di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) (DBDCT) in vivo. Environ Toxicol Pharmacol. 2017; 51:38-44. DOI: 10.1016/j.etap.2017.01.012. View

10.

Aslam B, Basit M, Nisar M, Khurshid M, Rasool M . Proteomics: Technologies and Their Applications. J Chromatogr Sci. 2017; 55(2):182-196. DOI: 10.1093/chromsci/bmw167. View

11.

Shih T, Fan Y, Kiss S, Li X, Deng X, Liu R . Galectin-1 inhibition induces cell apoptosis through dual suppression of CXCR4 and Ras pathways in human malignant peripheral nerve sheath tumors. Neuro Oncol. 2019; 21(11):1389-1400. PMC: 6827838. DOI: 10.1093/neuonc/noz093. View

12.

Zhang J, Zou Y, Cheng-Jing Y, Xiang-Heng L, Wang X, Yu X . Pioglitazone alleviates cisplatin nephrotoxicity by suppressing mitochondria-mediated apoptosis via SIRT1/p53 signalling. J Cell Mol Med. 2020; 24(20):11718-11728. PMC: 7578900. DOI: 10.1111/jcmm.15782. View

13.

Ramirez E, Sanchez-Maldonado C, Mayoral M, Mendieta L, Alatriste V, Patricio-Martinez A . Neuroinflammation induced by the peptide amyloid-β (25-35) increase the presence of galectin-3 in astrocytes and microglia and impairs spatial memory. Neuropeptides. 2019; 74:11-23. DOI: 10.1016/j.npep.2019.02.001. View

14.

Gao J, Tian X, Yan X, Wang Y, Wei J, Wang X . Selenium Exerts Protective Effects Against Fluoride-Induced Apoptosis and Oxidative Stress and Altered the Expression of Bcl-2/Caspase Family. Biol Trace Elem Res. 2020; 199(2):682-692. DOI: 10.1007/s12011-020-02185-w. View

15.

Boatright K, Salvesen G . Mechanisms of caspase activation. Curr Opin Cell Biol. 2003; 15(6):725-31. DOI: 10.1016/j.ceb.2003.10.009. View

16.

Huang Z, Ma L, Huang C, Li Q, Nice E . Proteomic profiling of human plasma for cancer biomarker discovery. Proteomics. 2016; 17(6). DOI: 10.1002/pmic.201600240. View

17.

Xu X, Lai Y, Hua Z . Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2018; 39(1). PMC: 6340950. DOI: 10.1042/BSR20180992. View

18.

Kovacs-Solyom F, Blasko A, Fajka-Boja R, Katona R, Vegh L, Novak J . Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett. 2009; 127(2):108-18. DOI: 10.1016/j.imlet.2009.10.003. View

19.

Changizi Z, Moslehi A, Rohani A, Eidi A . Chlorogenic acid induces 4T1 breast cancer tumor's apoptosis via p53, Bax, Bcl-2, and caspase-3 signaling pathways in BALB/c mice. J Biochem Mol Toxicol. 2020; 35(2):e22642. DOI: 10.1002/jbt.22642. View

20.

Brandt B, Abou-Eladab E, Tiedge M, Walzel H . Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death. Cell Death Dis. 2011; 1:e23. PMC: 3032336. DOI: 10.1038/cddis.2010.1. View